logo
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
logo
CONTACT US
CALL US
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us

Home » FDA Issues Recall for NaturaLyte Dialysis Concentrate

FDA Issues Recall for NaturaLyte Dialysis Concentrate

The FDA has issued a recall notice for NaturaLyte liquid bicarbonate concentrate manufactured by Fresenius Medical Care, NA. NaturaLyte is used in dialysis treatment for patients suffering from kidney failure. The recall was issued after laboratory testing identified the presence of bacteria in several samples. Fifty six lots of the product are being recalled and should be returned to the manufacturer.

In 2012, the FDA issued a Class I recall of Fresenius dialysis products GranuFlo and NaturaLyte after it learned of an internal study and memo issued by Fresenius about the use of these products in its own clinics. The memo reported 941 patients across 667 Fresenius Medical Care facilities suffered cardiac arrest during and soon after treatment. The study found that patients being treated with GranuFlo and NaturaLyte had a six to eight times increased risk for heart attack or sudden cardiac death within 48 hours of treatment.

Injured patients have filed lawsuits against Fresenius for failing to warn healthcare professionals and patients of the increased risk for cardiac events. Our product liability attorneys have talked with hundreds of dialysis patients who have used GranuFlo and NaturaLyte and have suffered serious personal injury. If you or someone you care about has used these dialysis products and suffered a serious cardiac event, contact us for a free case evaluation.

One Indiana Square Suite 1400
Indianapolis, Indiana 46204

Copyright ©  Cohen & Malad, LLP. All rights reserved.

Disclaimer  |  Privacy Policy

 

Schedule a free consultation Today
  • This field is for validation purposes and should be left unchanged.

Schedule a free consultation Today

  • This field is for validation purposes and should be left unchanged.

ALERTS

Former NFL Players Still Have Time to Claim Concussion Settlement Funds

It’s not too late for former National Football League players to claim their funds from the concussion .. Read More

SEE ALL ALERTS

In the News

Indiana Legal Services and Indiana State Bar Foundation Receive $90,000 donation from Cohen & Malad, LLP Class Action United Way of Central Indiana’s Center for Working Families Receives $32,000 from Cohen & Malad, LLP Settlement Funds Indianapolis Neighborhood Housing Partnership Receives $32,000 from Cohen & Malad, LLP Settlement Funds
READ OUR NEWS